Evidence map›Paper›PMID 41854410›Full record

ReviewYeast (Chichester, England)2026

CRISPR/Cas9 Genome Engineering in Non-Conventional Oleaginous Yeasts: Applications, Challenges, and Prospects.

Rodrigo Gonçalves Dias, Fernanda Pinheiro Moreira Freitas, Eduardo Luís Menezes de Almeida, Luciano Gomes Fietto, Agustin Zsögön, Wendel Batista da Silveira

Abstract readReview
In one paragraph

Review in Yeast (Chichester, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rodrigo Gonçalves DiasDepartment of Microbiology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.ORCID 0009-0001-5323-7541
Fernanda Pinheiro Moreira FreitasDepartment of Microbiology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.ORCID 0009-0008-5162-8929
Eduardo Luís Menezes de AlmeidaDepartment of Microbiology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.ORCID 0000-0002-3526-0975
Luciano Gomes FiettoDepartment of Biochemistry and Molecular Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.ORCID 0000-0003-4797-4075
Agustin ZsögönDepartment of Plant Biology, National Institute of Science and Technology on Plant Physiology Under Stress Conditions, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.ORCID 0000-0001-7828-7425
Wendel Batista da SilveiraDepartment of Microbiology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.ORCID 0000-0001-7869-8144

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the biotechnological potential of yeast-derived oils for oleochemical production, genes encoding lipid metabolism enzymes are key targets for metabolic engineering. Genetic engineering tools such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9, Transcription Activator-Like Effector Nucleases (TALENs), Zinc-Finger Nucleases (ZFNs), RNA interference (RNAi), and integrative plasmids can be used to modulate fatty acid biosynthesis and optimize lipid production. Among them, the CRISPR/Cas9 system, recognized for its simplicity and efficiency, has been deployed as a tool to create oleaginous yeast strains with high lipid productivity and features suitable for application in biorefineries. Species such as Cutaneotrichosporon oleaginosus, Rhodotorula toruloides, Candida spp., and Yarrowia lipolytica have already been engineered using CRISPR/Cas9 to enhance the production of fatty acids and their derivatives. However, designing and constructing an efficient CRISPR/Cas9 platform for oleaginous yeasts faces several hurdles, including low transformation efficiency, difficulties in expressing Cas9 and sgRNAs efficiently and consistently, the lack of well-characterized promoters, limited availability of PAM sequences, and poorly understood DNA repair mechanisms. Here, we address the application of the CRISPR/Cas9 system in oleaginous yeasts, laying out the challenges to developing efficient platforms and highlighting key trends in the field. We compare and discuss alternative CRISPR-Cas9 expression strategies to provide an overview of the current landscape and support the development of new approaches.

Indexed as

CRISPR-Cas SystemsGene EditingGenetic EngineeringMetabolic EngineeringYeastsFatty AcidsGenome, FungalLipid MetabolismFatty AcidsbiorefineriesCandida sppCutaneotrichosporon oleaginosusfatty acidsmetabolic engineeringRhodotorula toruloides

Identifiers

PMID41854410
PMCPMC13159405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.